Epitel raised $26 million in a Series B round to expand market access for its wireless electroencephalogram (EEG) platform aimed at seizure monitoring outside hospitals. The Remi remote EEG monitoring system is designed for home use, while the integrated Remi Vigilenz AI system uses machine learning to identify and flag seizure events. The company said the funding will support scaling reach and deployment. With seizure monitoring often limited by clinical staffing and infrastructure, home-based continuous diagnostics could shift adoption toward earlier intervention and more granular event capture. The financing underscores investor appetite for AI-assisted neuromonitoring tools that target operational bottlenecks in epilepsy care.